Synapticure
PrivateLast Round
Series A
Nov 19, 2024
Total Funding Raised
$37M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Synapticure is a healthcare technology company that provides a virtual clinical care platform to identify and treat patients' neurodegenerative diseases while providing integrated access to neurologists and behavioral health services.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Patient Engagement, Clinical Trials, Healthcare Analytics
Business Model
B2B2C
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Synapticure Comparables
Compare Synapticure with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Isaac Health | 85% | |
| Neuroglee Health | 83% | |
| Neura Health | 79% | |
Synapticure Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 19, 2024 | ||||
| Seed | Feb 1, 2022 | ||||
| Seed | Sep 1, 2021 |
Synapticure Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Series A |
| GV | Series A, Seed |
| B Capital Group | Series A |
| Nexus NeuroTech Ventures | Series A |
| Lifeforce Capital | Seed |
| Rock Health Capital | Series A |
| Byers Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2026
Collaborative Care Model adheres to University of Washington AIMS Center guidelines.
- Mar 1, 2026
Partnered with Centers for Medicare & Medicaid Services for dementia care model.
Synapticure Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Synapticure's valuation, stock price, and market status.